Bloom Burton & Co.
Claudia Hui is an Associate at Bloom Burton & Co., and joined as an Analyst in 2015. Claudia’s expertise helps the Bloom Burton team to identify and unlock value in healthcare companies. Her current role involves conducting technical (scientific, clinical, regulatory) and commercial due diligence and strategy consulting. Claudia has provided opportunity assessments and specialized scientific and market strategies for companies across all stages of development, with a particular focus and interest in academic, early stage biotechnology and digital health companies.
Claudia is a member of the Intellectual Property Advisory Committee for AllerGen NCE Inc., the Allergy, Genes and Environment Network.
Previously, Claudia worked as a Contract Consultant at Bloom Burton while completing her PhD in Infection and Immunity at McMaster University, specializing in allergy and immunology. She obtained her Master’s degree in Physiology and Pharmacology from McMaster University, specializing in asthma, and her Bachelor of Science in Physiology from McGill University
Bloom Burton & Co.
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton is comprised of medical, scientific, pharmaceutical, financial, legal and capital markets professionals with significant depth of experience. Their broad expertise enables them to take a creative, innovative, and entrepreneurial approach when assisting their clients with the achievement of the right monetization events.